Ceftriaxone (INN) is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria. In most cases, it is considered to be equivalent to cefotaxime in terms of safety and efficacy. Ceftriaxone sodium is marketed by Hoffman-La Roche under the trade name Rocephin, Rocetrax by Star Laboratories in Pakistan, as well as under various other names in several countries. Gepach International markets Ceftriaxone Injections under the brand name Cefatrin.